Vivos Therapeutics (VVOS) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-3.05
-2.07
-1.08
-0.1

Details

Expected EPS
-1.05
Actual EPS
-0.6
Surprise EPS
0.45
Surprise Percent
+42.86%

Description

Vivos Therapeutics (VVOS) has reported earnings of -0.6 per share for Q3 2024.

0 Comments

Share your thoughts